We may earn a commission from providers listed here, which can affect where they appear but never our ratings or reviews.
TopWeightLoss.us
Science6 min read

GLP-1 Medications and Mental Health: What Research Shows

How GLP-1 drugs may affect mood, anxiety, alcohol use and cravings, what patients report, the emotional blunting question, and what FDA reviews found.

Last updated September 15, 2026

Francheska Capistrano, Medical Content Reviewer

Francheska Capistrano, RMT, MPH

Clinically checked · Our review process

Key points

  • GLP-1 receptors are found in brain areas linked to reward and emotion, and patients often report less interest in alcohol, fewer compulsive urges and quieter thoughts about food.
  • Studies have found lower alcohol consumption on semaglutide, and trials are testing GLP-1s for alcohol, nicotine and opioid use disorders.
  • Mood changes are hard to separate from the effects of weight loss itself. Some patients report emotional blunting, and FDA and EMA reviews have not found a causal link between GLP-1s and post-marketing reports of suicidal ideation.
  • Watch your mood closely in the first months and after dose changes, and tell your provider about lasting low mood or numbness, especially if you have a history of depression or eating disorders.

Do GLP-1 medications act on the brain?

Yes. GLP-1 receptors are not limited to the gut and pancreas; they are spread widely through the brain, including regions that handle reward, emotional regulation and decision-making.

That has prompted researchers to study whether GLP-1 medications have neuropsychiatric effects beyond appetite control. Early findings are promising: some studies point to possible benefits for mood, anxiety and addictive behaviors, though the full picture is still unclear.

Our 2 favorite GLP-1 providers

The two providers our editors recommend first, with the same checked prices and scores used in our full ranking.

Our Most Popular
1
embody logo

Exceptional

9.8out of 10

Semaglutide from $69/mo, delivered in 1-2 days

Refund if not approvedFree expedited shipping

Treatments offered

Compounded semaglutide injection (GLP-1) · Compounded tirzepatide injection (GLP-1 + GIP) · Online doctor review and prescription · Dose changes through the patient portal

Starting price

$79$69/month

*Compounded medications are not FDA-approved.

  • Semaglutide $69/mo; tirzepatide $119/mo
  • 5-minute questionnaire; doctor review usually within 24 hours
  • Free 1-2 day shipping: cold-packed, tracked and insured
  • No insurance, no clinic visits, cancel anytime

from $69/month

Visit SiteRead full review
3.8Trustpilot(9,604)

embody prescribes compounded semaglutide at $69/mo and tirzepatide at $119/mo online, ships in 1-2 days, and requires no insurance. Trustpilot: 3.8 from 9,604 reviews.

Read full embody review
2
altRx logo

Exceptional

9.7out of 10

Low-cost GLP-1 care: semaglutide from $89/mo

Clear, flat pricingNo insurance needed

Treatments offered

Compounded semaglutide injection (GLP-1) · Compounded tirzepatide injection (GLP-1 + GIP) · Brand-name Ozempic, Zepbound and Wegovy · Once-weekly injection schedule

Starting price

$199$89/month

*Compounded medications are not FDA-approved.

  • Semaglutide from $89/mo; tirzepatide from $149/mo
  • Brand-name Ozempic, Zepbound and Wegovy available
  • Reviewed by a physician, PA or nurse practitioner
  • Free shipping, arriving in about 5-7 days

from $89/month

altRx sells compounded semaglutide from $89/month and tirzepatide from $149/month at a flat price per dose, plus brand-name Ozempic, Zepbound and Wegovy. Self-pay, no insurance needed.

Read full altRx review

What changes in mood and behavior do patients describe?

Patients on semaglutide and tirzepatide often describe effects beyond a smaller appetite:
  • Less interest in alcohol
  • Weaker urges toward compulsive habits such as gambling, shopping or scrolling
  • Quieter obsessive thoughts about food
  • Better mood and less anxiety, for some
  • Feeling emotionally flat or mildly depressed, for a smaller number
These accounts are anecdotal, but they are consistent enough to have led to formal research. Individual experiences vary widely.

Can GLP-1 drugs reduce alcohol cravings and addictive behavior?

Early evidence suggests they may. Several studies have found that people taking semaglutide drink less alcohol, and clinical trials are now testing it for alcohol use disorder, nicotine dependence and opioid addiction.

The leading explanation involves GLP-1 receptors in the brain's reward circuitry, the same pathways behind food cravings. By influencing dopamine signaling there, GLP-1 medications may blunt the reinforcing pull of addictive substances and behaviors.

Lowest-priced GLP-1 plans

The cheapest published plans, sorted from lowest price, with the terms listed under every price.

How do GLP-1s affect depression and anxiety?

The link is complicated. Weight loss on its own often eases depression and anxiety through better body image, easier movement and less inflammation, and it is hard to separate those indirect effects from any direct action of the drug on the brain.

Some preclinical studies suggest GLP-1 receptor activation reduces inflammation in the brain and may act on serotonin and dopamine pathways directly. Clinical trials looking specifically at psychiatric uses are underway but still early.

Is GLP-1 Treatment Right for You?

GLP-1 medication is prescription-only: a licensed clinician has to decide it is appropriate, and it is not a fit for everyone. Side effects are possible, and they tend to show up in the first few weeks while your body adapts.

Results are usually best when the medication is paired with simple daily habits, such as balanced meals and regular movement.

For both safety and lasting progress, pick a provider that screens you properly before prescribing and keeps following up once treatment starts.

Woman getting a GLP-1 weight loss injection pen ready

What mental health risks should GLP-1 patients know about?

Not every reported effect is positive. Some patients describe emotional blunting, a reduced ability to feel pleasure or a narrower emotional range, which some link to the drug's action on reward pathways.

There have also been post-marketing reports of suicidal ideation, although reviews by the FDA and the EMA have not established a causal link.

If you have a history of depression, eating disorders or other mental health conditions, discuss this with your provider before starting and report mood changes promptly. Our side effects guide covers the broader picture.

How should you monitor your mental health on a GLP-1?

Expect that mental health effects, good or bad, are possible, and pay attention to your mood, energy and emotional state, especially in the first few months and after dose changes.
  • Positive shifts, such as drinking less or fewer compulsive behaviors, match what many patients report.
  • Lasting low mood, emotional numbness or any worrying psychological change is a reason to contact your provider.
A provider with strong clinical oversight matters here. See what to look for or find your match with our quiz.

Which weight loss provider fits you best?

Our ranking compares the leading providers on price, clinical support and medication choices.

Popular provider matchups

Side-by-side comparisons with checked prices, the ones readers rely on most when choosing.

References and clinical sources

The medication facts on this page rest on FDA guidance and peer-reviewed clinical trials, while prices and plan terms come from what each provider publishes. Use this page as general information, not medical advice, and speak with a licensed clinician before you start any weight loss treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)